These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 16330578)

  • 21. Iodine-131 metaiodobenzylguanidine treatment for metastatic carcinoid. Results in 98 patients.
    Safford SD; Coleman RE; Gockerman JP; Moore J; Feldman J; Onaitis MW; Tyler DS; Olson JA
    Cancer; 2004 Nov; 101(9):1987-93. PubMed ID: 15455358
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term palliation in metastatic carcinoid tumours with various applications of meta-iodobenzylguanidin (MIBG): pharmacological MIBG, 131I-labelled MIBG and the combination.
    Zuetenhorst H; Taal BG; Boot H; Valdes Olmos R; Hoefnagel C
    Eur J Gastroenterol Hepatol; 1999 Oct; 11(10):1157-64. PubMed ID: 10524647
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Feasibility of dosimetry-based high-dose 131I-meta-iodobenzylguanidine with topotecan as a radiosensitizer in children with metastatic neuroblastoma.
    Gaze MN; Chang YC; Flux GD; Mairs RJ; Saran FH; Meller ST
    Cancer Biother Radiopharm; 2005 Apr; 20(2):195-9. PubMed ID: 15869455
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term outcome and toxicity after dose-intensified treatment with 131I-MIBG for advanced metastatic carcinoid tumors.
    Ezziddin S; Sabet A; Logvinski T; Alkawaldeh K; Yong-Hing CJ; Ahmadzadehfar H; Grünwald F; Biersack HJ
    J Nucl Med; 2013 Dec; 54(12):2032-8. PubMed ID: 24101685
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [131I]metaiodobenzylguanidine in neuroblastoma patients at diagnosis.
    Mastrangelo R; Lasorella A; Troncone L; Rufini V; Iavarone A; Riccardi R
    J Nucl Biol Med (1991); 1991; 35(4):252-4. PubMed ID: 1823829
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MIBG and radiolabeled octreotide in neuroendocrine tumors.
    Hoefnagel CA
    Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):137-9. PubMed ID: 9002773
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intraarterial 131I-MIBG therapy of neuroendocrine tumors with liver metastases.
    Popp M; Strumpf A; Zöphel K; Stroszczynski C; Kotzerke J
    Nuklearmedizin; 2010; 49(1):N2-3. PubMed ID: 20336828
    [No Abstract]   [Full Text] [Related]  

  • 28. Role of 131I-metaiodobenzylguanidine (MIBG) in the treatment of neuroendocrine tumours. Experience of the National Cancer Institute of Milan.
    Castellani MR; Chiti A; Seregni E; Bombardieri E
    Q J Nucl Med; 2000 Mar; 44(1):77-87. PubMed ID: 10932604
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Scintigraphy and treatment of medullary carcinoma of the thyroid with iodine-131 metaiodobenzylguanidine.
    Clarke SE; Lazarus CR; Edwards S; Murby B; Clarke DG; Roden TM; Fogelman I; Maisey MN
    J Nucl Med; 1987 Dec; 28(12):1820-5. PubMed ID: 3681441
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A scintigraphic comparison of iodine-123-metaiodobenzylguanidine and an iodine-labeled somatostatin analog (Tyr-3-octreotide) in metastatic carcinoid tumors.
    Bomanji J; Mather S; Moyes J; Ellison D; Grossman A; Britton KE; Besser GM
    J Nucl Med; 1992 Jun; 33(6):1121-4. PubMed ID: 1597726
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapy of neuroendocrine tumors with radiolabeled MIBG and somatostatin analogues.
    Wiseman GA; Kvols LK
    Semin Nucl Med; 1995 Jul; 25(3):272-8. PubMed ID: 7570046
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Diagnosis of pheochromocytoma by 131I-MIBG scintigraphy].
    Miyanaga N; Hattori K; Shiraiwa H; Hinotsu S; Nemoto R; Koiso K; Takeda T; Ishikawa N
    Hinyokika Kiyo; 1990 Feb; 36(2):105-8. PubMed ID: 2343801
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Whole-body PET/CT with 11C-meta-hydroxyephedrine in tumors of the sympathetic nervous system: feasibility study and comparison with 123I-MIBG SPECT/CT.
    Franzius C; Hermann K; Weckesser M; Kopka K; Juergens KU; Vormoor J; Schober O
    J Nucl Med; 2006 Oct; 47(10):1635-42. PubMed ID: 17015899
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Radionuclide diagnosis and therapy of neural crest tumors using iodine-131 metaiodobenzylguanidine.
    Hoefnagel CA; Voûte PA; de Kraker J; Marcuse HR
    J Nucl Med; 1987 Mar; 28(3):308-14. PubMed ID: 3102701
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Monitoring the efficacy of iodine-131-MIBG therapy using fluorine-18-FDG-PET.
    Menzel C; Graichen S; Berner U; Risse JH; Diehl M; Döbert N; Hamscho N; Grünwald F
    Acta Med Austriaca; 2003; 30(2):37-40. PubMed ID: 12752086
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term efficacy of low activity meta-[131I]iodobenzylguanidine therapy in patients with disseminated neuroendocrine tumours depends on initial response.
    Buscombe JR; Cwikla JB; Caplin ME; Hilson AJ
    Nucl Med Commun; 2005 Nov; 26(11):969-76. PubMed ID: 16208174
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preliminary results of [131I]metaiodobenzylguanidine treatment in metastatic carcinoid tumors.
    Colombo L; Vignati A; Lomuscio G; Dottorini ME
    J Nucl Biol Med (1991); 1991; 35(4):352-4. PubMed ID: 1823856
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comparison of targeting of neuroblastoma with mIBG and anti L1-CAM antibody mAb chCE7: therapeutic efficacy in a neuroblastoma xenograft model and imaging of neuroblastoma patients.
    Hoefnagel CA; Rutgers M; Buitenhuis CK; Smets LA; de Kraker J; Meli M; Carrel F; Amstutz H; Schubiger PA; Novak-Hofer I
    Eur J Nucl Med; 2001 Mar; 28(3):359-68. PubMed ID: 11315605
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Iodine-131-MIBG therapy of a patient with carcinoid liver metastases.
    Prvulovich EM; Stein RC; Bomanji JB; Ledermann JA; Taylor I; Ell PJ
    J Nucl Med; 1998 Oct; 39(10):1743-5. PubMed ID: 9776280
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 131I-MIBG Therapy in a Metastatic Small Bowel Neuroendocrine Tumor Patient Undergoing Hemodialysis.
    Rahimi B; Makis W; Riauka TA; McEwan AJ; Morrish D
    Clin Nucl Med; 2017 May; 42(5):350-353. PubMed ID: 28240668
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.